Breath-Actuated Metered Dose Inhaler

Inhalers, Breath Actuated Inhalers
Pharmaceutical, Inhalation

Aptar Pharma’s Breath Actuated Inhaler (BAI), is used in conjunction with a pressurized metered dose inhaler (pMDI) to automatically trigger the inhaler spray actuation when the patient is breathing in. This can greatly reduce patient coordination errors and improve their compliance for all patients with asthma and COPD.

Our BAI metered dose inhaler can also integrate a dose counting function to remind patients of the number of doses remaining for chronic respiratory conditions like asthma and COPD.

Aptar Pharma's white and blue Breath Actuated Inhaler (BAI) shown from a side angle for automatic spray actuation.
Aptar Pharma's white and blue Breath Actuated Inhaler (BAI) shown from a side angle for automatic spray actuation.
Aptar Pharma's white and blue Breath Actuated Inhaler (BAI) shown from the front for automatic spray actuation.
Aptar Pharma's white and blue Breath Actuated Inhaler (BAI) shown from a side angle with open door.
Aptar Pharma's white and blue Breath Actuated Inhaler (BAI) shown from a side angle with open door.

White and blue BAI inhaler device used to administer drug product by man in blue shirt with dark hair.

Designed with patients in mind

Aptar Pharma’s dedicated R&D teams designed the Breath-Actuated Inhaler to make the inhalation process easier for patients suffering from asthma or COPD. Patient compliance is critical for these chronic diseases in order to manage their care. Our BAI is simple to use for patients of all ages, including children and the elderly. It is small, lightweight, and can easily be carried in a purse, pocket or bag for portability.

Patients simply place the mouthpiece in their mouth and breathe in. The BAI senses the inhalation and automatically coordinates the actuation of the metering valve to release the product spray. This means the patient does not have to even think about coordinating inhalation with actuation, like they would with conventional pMDI inhaler systems. Some patients with low inspiration rates (flow rates) can benefit from Breath Actuated Inhalers as they ensure higher levels of dose consistency.

Side view of a woman in a brown shirt with shoulder length brown hair holding Aptar's white and blue BAI device.

Enhances Patient Compliance

A breath-actuated inhaler can enhance patient compliance as it makes the drug delivery process simple and essentially eliminates coordination errors. Our BAI coordinates the release of the drug product from the metering valve, which helps to overcome patient coordination errors and the need for high inspiration (flow) rates. By minimizing patient errors via this technology, the BAI delivers higher patient compliance and adherence. Aptar Pharma’s Breath Actuated Inhalers are designed with the patient user in mind. They are small, lightweight, and portable, capable of fitting in purses, pockets, or bags so they are ideal for staying with the patient. Always ready when needed.

In addition, our BAI devices include an integrated dose counting mechanism so the patient can always have confidence in the number of doses remaining and help track doses taken. Aptar Pharma matches the metering valve with both the BAI triggering and dose-counting mechanisms resulting in a fully integrated and intuitive solution that is easy to use by patients.

Angled view of six of Aptar Pharma's BAI inhalers in a range of colors for product differentiation.

Lifecycle Management Opportunities

Utilizing Aptar Pharma’s BAI opens numerous lifecycle management opportunities and can support brand differentiation strategies. Our proprietary Breath-Actuated Inhaler technology provides many functional advantages for your inhaler product. We can integrate our BAI, optimized metering valves, and digital dose counter in one single device that comes in a range of color options, which open a world of product differentiation opportunities. Whether it’s a new inhalation product or a repositioned drug product, Aptar Pharma’s Breath-actuated inhaler can prove a viable option for inhalation products.

Two men sitting at laboratory benchtop in white lab coats review oral liquid product development data beside microscope.

Integrated Support and Development Services

Aptar Pharma’s BAI is our fully integrated pressurized metered dose inhaler (pMDI) inhalation system that enhances patient compliance. We also offer fully integrated support and development services including analytical and formulation development as well as regulatory support to help bring customer inhalation products to market sooner and more efficiently. We add value at every stage of the drug-development process, accelerating and reducing the risk of programs along the way with our experience and specialized expertise.

Breath Actuated Inhaler Advantages

 

We Thrive On Helping You Transform Your Ideas Into Commercial Opportunities.

We can accelerate and reduce the risk of your inhalation drug-development project with our comprehensive range of value added services.

We Have a Broad Range of Value Added Services to Accelerate and Derisk
Your Drug Product Development.

Start a Project With Us

We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.

We Offer World-Leading Support Services for You at Every Stage of Your Product Development

Explore How We Serve Your Market